0.5 ML asparaginase Erwinia chrysanthemi (recombinant)-rywn 20 MG/ML Injection
RxNorm concept 2561251, clinical drug (scd). Prescribable name: asparaginase Erwinia chrysanthemi (recombinant)-rywn 10 MG in 0.5 ML Injection.
- RxCUI
- 2561251
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2561251 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
asparaginase Erwinia chrysanthemi (recombinant)-rywn 10 MG per 0.5 ML Injection
Related concepts
- asparaginase Erwinia chrysanthemi (recombinant)-rywn 20 MG/ML (SCDC, consists of)
- Injection (DF, has dose form)
- 0.5 ML asparaginase Erwinia chrysanthemi (recombinant)-rywn 20 MG/ML Injection [Rylaze] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2561251 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2561251 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2561251. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.